Literature DB >> 17436253

Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitus.

F Lucy Raymond1, Patrick S Tarpey, Sarah Edkins, Calli Tofts, Sarah O'Meara, Jon Teague, Adam Butler, Claire Stevens, Syd Barthorpe, Gemma Buck, Jennifer Cole, Ed Dicks, Kristian Gray, Kelly Halliday, Katy Hills, Jonathon Hinton, David Jones, Andrew Menzies, Janet Perry, Keiran Raine, Rebecca Shepherd, Alexandra Small, Jennifer Varian, Sara Widaa, Uma Mallya, Jenny Moon, Ying Luo, Marie Shaw, Jackie Boyle, Bronwyn Kerr, Gillian Turner, Oliver Quarrell, Trevor Cole, Douglas F Easton, Richard Wooster, Martin Bobrow, Charles E Schwartz, Jozef Gecz, Michael R Stratton, P Andrew Futreal.   

Abstract

We have identified one frameshift mutation, one splice-site mutation, and two missense mutations in highly conserved residues in ZDHHC9 at Xq26.1 in 4 of 250 families with X-linked mental retardation (XLMR). In three of the families, the mental retardation phenotype is associated with a Marfanoid habitus, although none of the affected individuals meets the Ghent criteria for Marfan syndrome. ZDHHC9 is a palmitoyltransferase that catalyzes the posttranslational modification of NRAS and HRAS. The degree of palmitoylation determines the temporal and spatial location of these proteins in the plasma membrane and Golgi complex. The finding of mutations in ZDHHC9 suggests that alterations in the concentrations and cellular distribution of target proteins are sufficient to cause disease. This is the first XLMR gene to be reported that encodes a posttranslational modification enzyme, palmitoyltransferase. Furthermore, now that the first palmitoyltransferase that causes mental retardation has been identified, defects in other palmitoylation transferases become good candidates for causing other mental retardation syndromes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17436253      PMCID: PMC1852737          DOI: 10.1086/513609

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  Synaptic strength regulated by palmitate cycling on PSD-95.

Authors:  Alaa El-Din El-Husseini; Eric Schnell; Srikanth Dakoji; Neal Sweeney; Qiang Zhou; Oliver Prange; Catherine Gauthier-Campbell; Andrea Aguilera-Moreno; Roger A Nicoll; David S Bredt
Journal:  Cell       Date:  2002-03-22       Impact factor: 41.582

2.  Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.

Authors:  Stéphane Jamain; Hélène Quach; Catalina Betancur; Maria Råstam; Catherine Colineaux; I Carina Gillberg; Henrik Soderstrom; Bruno Giros; Marion Leboyer; Christopher Gillberg; Thomas Bourgeron
Journal:  Nat Genet       Date:  2003-05       Impact factor: 38.330

3.  Regulation of dendritic branching and filopodia formation in hippocampal neurons by specific acylated protein motifs.

Authors:  Catherine Gauthier-Campbell; David S Bredt; Timothy H Murphy; Alaa El-Din El-Husseini
Journal:  Mol Biol Cell       Date:  2004-02-20       Impact factor: 4.138

Review 4.  Spatio-temporal segregation of Ras signals: one ship, three anchors, many harbors.

Authors:  Oliver Rocks; Anna Peyker; Philippe I H Bastiaens
Journal:  Curr Opin Cell Biol       Date:  2006-06-16       Impact factor: 8.382

5.  Revised diagnostic criteria for the Marfan syndrome.

Authors:  A De Paepe; R B Devereux; H C Dietz; R C Hennekam; R E Pyeritz
Journal:  Am J Med Genet       Date:  1996-04-24

6.  A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar heterotopia and lissencephaly syndrome.

Authors:  V des Portes; J M Pinard; P Billuart; M C Vinet; A Koulakoff; A Carrié; A Gelot; E Dupuis; J Motte; Y Berwald-Netter; M Catala; A Kahn; C Beldjord; J Chelly
Journal:  Cell       Date:  1998-01-09       Impact factor: 41.582

7.  Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation.

Authors:  K Kutsche; H Yntema; A Brandt; I Jantke; H G Nothwang; U Orth; M G Boavida; D David; J Chelly; J P Fryns; C Moraine; H H Ropers; B C Hamel; H van Bokhoven; A Gal
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

8.  Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome).

Authors:  R J Gibbons; D J Picketts; L Villard; D R Higgs
Journal:  Cell       Date:  1995-03-24       Impact factor: 41.582

9.  Protein-truncating mutations in ASPM cause variable reduction in brain size.

Authors:  Jacquelyn Bond; Sheila Scott; Daniel J Hampshire; Kelly Springell; Peter Corry; Marc J Abramowicz; Ganesh H Mochida; Raoul C M Hennekam; Eamonn R Maher; Jean-Pierre Fryns; Abdulrahman Alswaid; Hussain Jafri; Yasmin Rashid; Ammar Mubaidin; Christopher A Walsh; Emma Roberts; C Geoffrey Woods
Journal:  Am J Hum Genet       Date:  2003-10-21       Impact factor: 11.025

10.  Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation.

Authors:  Patrick Tarpey; Josep Parnau; Matthew Blow; Hayley Woffendin; Graham Bignell; Charles Cox; James Cox; Helen Davies; Sarah Edkins; Simon Holden; Angelique Korny; Uma Mallya; Jenny Moon; Sarah O'Meara; Adrian Parker; Philip Stephens; Claire Stevens; Jon Teague; Andrew Donnelly; Marie Mangelsdorf; John Mulley; Michael Partington; Gillian Turner; Roger Stevenson; Charles Schwartz; Ian Young; Douglas Easton; Martin Bobrow; P Andrew Futreal; Michael R Stratton; Jozef Gecz; Richard Wooster; F Lucy Raymond
Journal:  Am J Hum Genet       Date:  2004-06-07       Impact factor: 11.025

View more
  69 in total

1.  Detection of clinically relevant exonic copy-number changes by array CGH.

Authors:  Philip M Boone; Carlos A Bacino; Chad A Shaw; Patricia A Eng; Patricia M Hixson; Amber N Pursley; Sung-Hae L Kang; Yaping Yang; Joanna Wiszniewska; Beata A Nowakowska; Daniela del Gaudio; Zhilian Xia; Gayle Simpson-Patel; LaDonna L Immken; James B Gibson; Anne C-H Tsai; Jennifer A Bowers; Tyler E Reimschisel; Christian P Schaaf; Lorraine Potocki; Fernando Scaglia; Tomasz Gambin; Maciej Sykulski; Magdalena Bartnik; Katarzyna Derwinska; Barbara Wisniowiecka-Kowalnik; Seema R Lalani; Frank J Probst; Weimin Bi; Arthur L Beaudet; Ankita Patel; James R Lupski; Sau Wai Cheung; Pawel Stankiewicz
Journal:  Hum Mutat       Date:  2010-11-02       Impact factor: 4.878

Review 2.  Infantile hypertrophic pyloric stenosis--genetics and syndromes.

Authors:  Babette Peeters; Marc A Benninga; Raoul C M Hennekam
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-10       Impact factor: 46.802

3.  Palmitoylation by Multiple DHHC Enzymes Enhances Dopamine Transporter Function and Stability.

Authors:  Danielle E Bolland; Amy E Moritz; Daniel J Stanislowski; Roxanne A Vaughan; James D Foster
Journal:  ACS Chem Neurosci       Date:  2019-04-19       Impact factor: 4.418

4.  DHHC5 interacts with PDZ domain 3 of post-synaptic density-95 (PSD-95) protein and plays a role in learning and memory.

Authors:  Yi Li; Jie Hu; Klemens Höfer; Andrew M S Wong; Jonathan D Cooper; Shari G Birnbaum; Robert E Hammer; Sandra L Hofmann
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

5.  Mutations in ionotropic AMPA receptor 3 alter channel properties and are associated with moderate cognitive impairment in humans.

Authors:  Ye Wu; Amy C Arai; Gavin Rumbaugh; Anand K Srivastava; Gillian Turner; Takashi Hayashi; Erika Suzuki; Yuwu Jiang; Lilei Zhang; Jayson Rodriguez; Jackie Boyle; Patrick Tarpey; F Lucy Raymond; Joke Nevelsteen; Guy Froyen; Mike Stratton; Andy Futreal; Jozef Gecz; Roger Stevenson; Charles E Schwartz; David Valle; Richard L Huganir; Tao Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

Review 6.  Discovery of protein-palmitoylating enzymes.

Authors:  Ryouhei Tsutsumi; Yuko Fukata; Masaki Fukata
Journal:  Pflugers Arch       Date:  2008-01-30       Impact factor: 3.657

7.  Tracking brain palmitoylation change: predominance of glial change in a mouse model of Huntington's disease.

Authors:  Junmei Wan; Jeffrey N Savas; Amy F Roth; Shaun S Sanders; Roshni R Singaraja; Michael R Hayden; John R Yates; Nicholas G Davis
Journal:  Chem Biol       Date:  2013-11-07

8.  Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling.

Authors:  Sonia L Planey; Susan K Keay; Chen-Ou Zhang; David A Zacharias
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

9.  The palmitoyl acyltransferases ZDHHC5 and ZDHHC8 are uniquely present in DRG axons and control retrograde signaling via the Gp130/JAK/STAT3 pathway.

Authors:  Kaitlin M Collura; Jingwen Niu; Shaun S Sanders; Audrey Montersino; Sabrina M Holland; Gareth M Thomas
Journal:  J Biol Chem       Date:  2020-09-21       Impact factor: 5.157

10.  2-Bromopalmitate and 2-(2-hydroxy-5-nitro-benzylidene)-benzo[b]thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro.

Authors:  Benjamin C Jennings; Marissa J Nadolski; Yiping Ling; Meredith Beckham Baker; Marietta L Harrison; Robert J Deschenes; Maurine E Linder
Journal:  J Lipid Res       Date:  2008-09-30       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.